$STRR
STAR EQUITY HOLDINGS, INC.

2013 Q4 Form 10-Q Financial Statement

#000070738813000046 Filed on November 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q4
Revenue $12.53M $12.41M $13.02M
YoY Change -3.76% 5.04% 9.55%
Cost Of Revenue $8.840M $8.595M $10.41M
YoY Change -15.08% -1.07% 18.43%
Gross Profit $3.688M $3.818M $2.610M
YoY Change 41.3% 22.02% -15.64%
Gross Profit Margin 29.44% 30.76% 20.05%
Selling, General & Admin $2.820M $2.796M $3.690M
YoY Change -23.58% -9.57% -26.64%
% of Gross Profit 76.46% 73.23% 141.38%
Research & Development $10.00K $24.00K $720.0K
YoY Change -98.61% -97.73% 18.03%
% of Gross Profit 0.27% 0.63% 27.59%
Depreciation & Amortization $460.0K $475.0K $480.0K
YoY Change -4.17% -9.35% -23.81%
% of Gross Profit 12.47% 12.44% 18.39%
Operating Expenses $2.870M $1.386M $4.450M
YoY Change -35.51% -66.97% -22.2%
Operating Profit $780.0K $2.432M -$1.843M
YoY Change -142.32% -327.93% -27.07%
Interest Expense $10.00K $5.000K $20.00K
YoY Change -50.0% 150.0% -110.0%
% of Operating Profit 1.28% 0.21%
Other Income/Expense, Net $8.000K
YoY Change -69.23%
Pretax Income $790.0K $2.440M -$1.830M
YoY Change -143.17% -334.39% -35.34%
Income Tax $0.00 -$72.00K $30.00K
% Of Pretax Income 0.0% -2.95%
Net Earnings $787.0K $2.512M -$1.859M
YoY Change -142.33% -377.26% -34.24%
Net Earnings / Revenue 6.28% 20.24% -14.28%
Basic Earnings Per Share $0.04 $0.14
Diluted Earnings Per Share $0.04 $0.14 -$963.7K
COMMON SHARES
Basic Shares Outstanding 18.42M shares 18.33M shares 20.22M shares
Diluted Shares Outstanding 18.58M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.40M $25.90M $27.20M
YoY Change -2.94% -4.78% -10.82%
Cash & Equivalents $18.74M $17.64M $19.51M
Short-Term Investments $7.700M $8.300M $7.700M
Other Short-Term Assets $697.0K $519.0K $642.0K
YoY Change 8.57% -28.12% -24.91%
Inventory $3.881M $4.413M $4.979M
Prepaid Expenses
Receivables $5.430M $6.077M $6.329M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $36.67M $37.19M $39.39M
YoY Change -6.9% -10.54% -10.48%
LONG-TERM ASSETS
Property, Plant & Equipment $4.153M $4.111M $4.693M
YoY Change -11.51% -20.14% -12.56%
Goodwill $184.0K $184.0K $184.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles $353.0K $406.0K $584.0K
YoY Change -39.55% 38.57% 22.43%
Long-Term Investments
YoY Change
Other Assets $92.00K $90.00K $61.00K
YoY Change 50.82%
Total Long-Term Assets $4.782M $4.791M $5.522M
YoY Change -13.4% -14.83% -8.39%
TOTAL ASSETS
Total Short-Term Assets $36.67M $37.19M $39.39M
Total Long-Term Assets $4.782M $4.791M $5.522M
Total Assets $41.45M $41.98M $44.91M
YoY Change -7.7% -11.05% -10.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $611.0K $1.720M $1.546M
YoY Change -60.48% -9.76% 16.24%
Accrued Expenses $5.400M $3.600M $2.700M
YoY Change 100.0% -30.77% -46.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.625M $8.409M $8.284M
YoY Change -7.96% -5.29% -1.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $440.0K $264.0K $176.0K
YoY Change 150.0% 32.0% 76.0%
Total Long-Term Liabilities $440.0K $264.0K $176.0K
YoY Change 150.0% 32.0% 76.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.625M $8.409M $8.284M
Total Long-Term Liabilities $440.0K $264.0K $176.0K
Total Liabilities $8.065M $8.673M $8.460M
YoY Change -4.67% -4.09% -0.94%
SHAREHOLDERS EQUITY
Retained Earnings -$117.9M -$118.6M -$118.1M
YoY Change -0.22% 2.05% 4.35%
Common Stock $2.000K $2.000K $2.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.728M $5.728M $2.086M
YoY Change 174.59% 174.46% 97.16%
Treasury Stock Shares 2.588M shares 2.558M shares 1.074M shares
Shareholders Equity $33.39M $33.31M $36.45M
YoY Change
Total Liabilities & Shareholders Equity $41.45M $41.98M $44.91M
YoY Change -7.7% -11.05% -10.23%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q4
OPERATING ACTIVITIES
Net Income $787.0K $2.512M -$1.859M
YoY Change -142.33% -377.26% -34.24%
Depreciation, Depletion And Amortization $460.0K $475.0K $480.0K
YoY Change -4.17% -9.35% -23.81%
Cash From Operating Activities $1.380M $2.380M $540.0K
YoY Change 155.56% -595.83% -150.94%
INVESTING ACTIVITIES
Capital Expenditures -$110.0K -$110.0K -$60.00K
YoY Change 83.33% -77.08% -50.0%
Acquisitions
YoY Change
Other Investing Activities $620.0K $2.580M $680.0K
YoY Change -8.82% 290.91% -95.45%
Cash From Investing Activities $520.0K $2.460M $620.0K
YoY Change -16.13% 1266.67% -95.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -790.0K -160.0K 0.000
YoY Change -58.97% -100.0%
NET CHANGE
Cash From Operating Activities 1.380M 2.380M 540.0K
Cash From Investing Activities 520.0K 2.460M 620.0K
Cash From Financing Activities -790.0K -160.0K 0.000
Net Change In Cash 1.110M 4.680M 1.160M
YoY Change -4.31% -778.26% -91.59%
FREE CASH FLOW
Cash From Operating Activities $1.380M $2.380M $540.0K
Capital Expenditures -$110.0K -$110.0K -$60.00K
Free Cash Flow $1.490M $2.490M $600.0K
YoY Change 148.33% -1425929142272000000.0% -163.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1720000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1546000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6329000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6077000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-103000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-148000 USD
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21477000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21301000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
576000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
527000 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
157695000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
156634000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
178000 USD
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
49000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
184000 USD
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
55000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
436000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
353000 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
350000 shares
CY2013Q3 us-gaap Assets
Assets
41983000 USD
CY2012Q4 us-gaap Assets
Assets
44909000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
37192000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
39387000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
7679000 USD
CY2013Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
8301000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17638000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19514000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18343000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24039000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5696000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1876000 USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-313000 USD
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18418896 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19144448 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19144448 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18418896 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
2000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3039000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-558000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-874000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2535000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26421000 USD
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8595000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27015000 USD
CY2012Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8688000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1808000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
5501000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1679000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
6250000 USD
us-gaap Cost Of Services
CostOfServices
20765000 USD
CY2013Q3 us-gaap Cost Of Services
CostOfServices
6916000 USD
CY2012Q3 us-gaap Cost Of Services
CostOfServices
6880000 USD
us-gaap Cost Of Services
CostOfServices
20920000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1849000 USD
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1494000 USD
us-gaap Depreciation
Depreciation
1466000 USD
us-gaap Depreciation
Depreciation
1269000 USD
CY2013Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
475000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1447000 USD
CY2012Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
524000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1650000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-351000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
777000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-167000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-873000 USD
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-133000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2364000 USD
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3454000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1568000 USD
CY2012Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2013Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1568000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
48000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1623000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5820000 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1744000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1754000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6427000 USD
CY2013Q3 us-gaap Goodwill
Goodwill
184000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
184000 USD
us-gaap Gross Profit
GrossProfit
10428000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
3129000 USD
us-gaap Gross Profit
GrossProfit
10482000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
3818000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2440000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-567000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1041000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3176000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-72000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-44000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-135000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-111000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
167000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-694000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-355000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
445000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1090000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-94000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
50000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-1122000 USD
CY2013Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
250000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
406000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
584000 USD
us-gaap Interest Expense
InterestExpense
10000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
2000 USD
us-gaap Interest Expense
InterestExpense
3000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
5000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1861000 USD
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1178000 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
7544000 USD
CY2013Q3 us-gaap Inventory Gross
InventoryGross
7294000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
4979000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
4413000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2522000 USD
CY2013Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2653000 USD
CY2013Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2881000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2565000 USD
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
3463000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3161000 USD
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
28000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
52000 USD
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
13000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
82000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
8673000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
8460000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41983000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44909000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8409000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8284000 USD
CY2013Q3 us-gaap Loss Contingency Settlement Agreement Consideration1
LossContingencySettlementAgreementConsideration1
385000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
880000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The Company</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Digirad Corporation (&#8220;Digirad&#8221;), a Delaware corporation, is one of the largest national providers of in-office nuclear cardiology imaging and ultrasound services to physician practices, hospitals and imaging centers through our Digirad Imaging Solutions (&#8220;DIS&#8221;) segment. Through DIS, we provide in-office imaging services to physicians, offering certified personnel, required licensure, an imaging system and other support and supplies for the performance of nuclear and ultrasound imaging procedures under the supervision of our physician customers. DIS' physician customers enter into service contracts for imaging services generally delivered on a per-day basis. We also sell medical diagnostic imaging systems including solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provide service on the products we sell through our Diagnostic Imaging segment. These </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments, DIS and Diagnostic Imaging, are collectively referred to herein as the &#8220;Company.&#8221; </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements include the operations of both segments. Intercompany accounts and transactions are accounted for at cost and have been eliminated in consolidation. All our long-lived assets are located in the United States and substantially all of our revenues arise from sales activity in the United States. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements included in this Form 10-Q have been prepared in accordance with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) instructions for Quarterly Reports on Form 10-Q. Accordingly, the condensed consolidated financial statements are unaudited and do not contain all the information required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) to be included in a full set of financial statements. The unaudited condensed consolidated balance sheet at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;"> has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by GAAP for a complete set of financial statements. The audited consolidated financial statements for our fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC on Form 10-K on March 13, 2013 include a summary of our significant accounting policies and should be read in conjunction with this Form 10-Q. In the opinion of management, all material adjustments necessary to present fairly the results of operations, cash flows and balance sheets for such periods have been included in this Form 10-Q. All such adjustments are of a normal recurring nature. In addition certain reclassifications have been made to the prior period financial statements to conform to the current period presentation. The results of operations for interim periods are not necessarily indicative of the results of operations for the entire year.</font></div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2949000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-733000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3339000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
254000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
819000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1624000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-906000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3065000 USD
us-gaap Net Income Loss
NetIncomeLoss
-523000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
2512000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
42000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
79000 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Operating Expenses
OperatingExpenses
13737000 USD
us-gaap Operating Expenses
OperatingExpenses
11037000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
4196000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
1386000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2432000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1067000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3255000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-609000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2199000 USD
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1608000 USD
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
519000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
642000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
90000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
61000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-35000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
26000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
32000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
23000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
32000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
26000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1029000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
176000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
264000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3640000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4679000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4887000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
617000 USD
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
296000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
760000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2365000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3874000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1676000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
63000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
326000 USD
CY2013Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
133000 USD
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25588000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25994000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4111000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4693000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-60000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-17000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
69000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1055000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2998000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1020000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
244000 USD
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
244000 USD
us-gaap Restructuring Charges
RestructuringCharges
1693000 USD
CY2012Q3 us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2013Q3 us-gaap Restructuring Charges
RestructuringCharges
79000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
CY2013Q3 us-gaap Restructuring Reserve
RestructuringReserve
571000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118641000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118118000 USD
us-gaap Revenues
Revenues
36849000 USD
CY2013Q3 us-gaap Revenues
Revenues
12413000 USD
CY2012Q3 us-gaap Revenues
Revenues
11817000 USD
us-gaap Revenues
Revenues
37497000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2924000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8946000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2961000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9975000 USD
CY2013Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
9489000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
27903000 USD
CY2012Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
8856000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
27522000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1500000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1200000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3287000 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1042000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4735000 USD
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1348000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
300000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
471000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
36449000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
33310000 USD
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2558484 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1073641 shares
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
5728000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2086000 USD
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19263000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19273000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18890000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18580000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19273000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18328000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19263000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18890000 shares
CY2013Q3 digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
2000 shares
CY2012Q3 digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000707388
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18423063 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
DIGIRAD CORP

Files In Submission

Name View Source Status
0000707388-13-000046-index-headers.html Edgar Link pending
0000707388-13-000046-index.html Edgar Link pending
0000707388-13-000046.txt Edgar Link pending
0000707388-13-000046-xbrl.zip Edgar Link pending
digirad-20130930.xml Edgar Link completed
digirad-20130930.xsd Edgar Link pending
digirad-20130930_cal.xml Edgar Link unprocessable
digirad-20130930_def.xml Edgar Link unprocessable
digirad-20130930_lab.xml Edgar Link unprocessable
digirad-20130930_pre.xml Edgar Link unprocessable
drad-9302013x10q.htm Edgar Link pending
drad-9302013xex311.htm Edgar Link pending
drad-9302013xex312.htm Edgar Link pending
drad-9302013xex321.htm Edgar Link pending
drad-9302013xex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending